These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1107 related articles for article (PubMed ID: 30579043)

  • 1. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing Dendritic Cells for Poly (D,L-lactide-
    Koerner J; Horvath D; Groettrup M
    Front Immunol; 2019; 10():707. PubMed ID: 31024545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.
    Hamdy S; Haddadi A; Hung RW; Lavasanifar A
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):943-55. PubMed ID: 21679733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
    Nakamura T
    Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle mediated cancer immunotherapy.
    Gupta J; Safdari HA; Hoque M
    Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy.
    Manspeaker MP; Thomas SN
    Adv Drug Deliv Rev; 2020; 160():19-35. PubMed ID: 33058931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoparticles for cancer immunotherapy.
    Saleh T; Shojaosadati SA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Delivery for Cancer Immunotherapy and Vaccines.
    Batty CJ; Tiet P; Bachelder EM; Ainslie KM
    Pharm Nanotechnol; 2018; 6(4):232-244. PubMed ID: 30227827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrageenan: A Wonder Polymer from Marine Algae for Potential Drug Delivery Applications.
    Qureshi D; Nayak SK; Maji S; Kim D; Banerjee I; Pal K
    Curr Pharm Des; 2019; 25(11):1172-1186. PubMed ID: 31465278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy.
    Fu S; Li G; Zang W; Zhou X; Shi K; Zhai Y
    Acta Pharm Sin B; 2022 Jan; 12(1):92-106. PubMed ID: 35127374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Part I: targeted particles for cancer immunotherapy.
    Hamdy S; Haddadi A; Ghotbi Z; Hung RW; Lavasanifar A
    Curr Drug Deliv; 2011 May; 8(3):261-73. PubMed ID: 21453265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.
    Badiee A; Heravi Shargh V; Khamesipour A; Jaafari MR
    Vaccine; 2013 Jan; 31(5):735-49. PubMed ID: 23219436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable hydrogels for personalized cancer immunotherapies.
    Mohaghegh N; Ahari A; Zehtabi F; Buttles C; Davani S; Hoang H; Tseng K; Zamanian B; Khosravi S; Daniali A; Kouchehbaghi NH; Thomas I; Serati Nouri H; Khorsandi D; Abbasgholizadeh R; Akbari M; Patil R; Kang H; Jucaud V; Khademhosseini A; Hassani Najafabadi A
    Acta Biomater; 2023 Dec; 172():67-91. PubMed ID: 37806376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy.
    Fan X; Wang K; Lu Q; Lu Y; Sun J
    Small; 2023 Jan; 19(4):e2205166. PubMed ID: 36437050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy.
    Fan Y; Moon JJ
    Vaccines (Basel); 2015 Aug; 3(3):662-85. PubMed ID: 26350600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
    Li S; Bennett ZT; Sumer BD; Gao J
    Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment.
    Zhao H; Zhao B; Wu L; Xiao H; Ding K; Zheng C; Song Q; Sun L; Wang L; Zhang Z
    ACS Nano; 2019 Nov; 13(11):12553-12566. PubMed ID: 31689085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles and microparticles as vaccine-delivery systems.
    Singh M; Chakrapani A; O'Hagan D
    Expert Rev Vaccines; 2007 Oct; 6(5):797-808. PubMed ID: 17931159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.